Employees: 03 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 1996-04-16 (30 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: EVREUX (27000), Eure
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
LABORATOIRES LAFRAN : revenue, balance sheet and financial ratios
LABORATOIRES LAFRAN is a French company
founded 30 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in EVREUX (27000),
this company of category PME
shows in 2024 a net income positive of 33 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LABORATOIRES LAFRAN (SIREN 408163467)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
32 690 €
1 051 276 €
544 971 €
1 001 909 €
1 047 282 €
613 695 €
545 750 €
637 532 €
783 313 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, LABORATOIRES LAFRAN generates positive net income of 33 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 783 k€ -> 33 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
32 690 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 28%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
28.215%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
62.361%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
5.202
2.852
0.357
0.298
0.081
54.64
53.982
42.678
28.215
Financial autonomy
51.543
63.662
63.861
73.871
81.19
50.324
50.966
53.9
62.361
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
28.212024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Average-10 pts over 3 years
In 2024, the debt ratio of LABORATOIRES LAFRAN (28.21) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
62.36%2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Excellent+10 pts over 3 years
In 2024, the financial autonomy of LABORATOIRES LAFRAN (62.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 498.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
213.104
282.419
279.95
397.088
565.744
466.481
437.021
427.924
498.876
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
498.882024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Excellent
In 2024, the liquidity ratio of LABORATOIRES LAFRAN (498.88) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of LABORATOIRES LAFRAN in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of LABORATOIRES LAFRAN is estimated at
26 855 €
(range 10 221€ - 98 072€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
124 transactions
10k€26k€98k€
26 855 €Range: 10 221€ - 98 072€
NAF 5 all-time
Valuation method used
Net Income Multiple
32 690 €
×
0.8x
=26 855 €
Range: 10 221€ - 98 072€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare LABORATOIRES LAFRAN with other companies in the same sector:
Frequently asked questions about LABORATOIRES LAFRAN
What is the revenue of LABORATOIRES LAFRAN ?
The revenue of LABORATOIRES LAFRAN is not publicly disclosed (confidential accounts filed with INPI).
Is LABORATOIRES LAFRAN profitable?
Yes, LABORATOIRES LAFRAN generated a net profit of 33 k€ in 2024.
Where is the headquarters of LABORATOIRES LAFRAN ?
The headquarters of LABORATOIRES LAFRAN is located in EVREUX (27000), in the department Eure.
Where to find the tax return of LABORATOIRES LAFRAN ?
The tax return of LABORATOIRES LAFRAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LABORATOIRES LAFRAN operate?
LABORATOIRES LAFRAN operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart